research use only
Cat.No.P1275
CAS No. 2581741-18-4
| Featured Inhibitors | Y-27632 Dihydrochloride SB431542 CHIR-99021 (Laduviglusib) RMC-7977 RMC-6236 (Daraxonrasib) MRTX1133 MG132 Z-VAD-FMK VT3989 IAG933 |
|---|
| Storage (From the date of receipt) | |||
|
In vitro |
DMSO
: 100 mg/mL
(67.99 mM);
Water : 100 mg/mL Ethanol : 3 mg/mL |
Molecular Weight Calculator |
|
In vivo Add solvents to the product individually and in order. |
In vivo Formulation Calculator |
||||
| Description | Rofapitide tetraxetan (FAP-2286) is a potent and selective FAP-binding peptidic macrocycle conjugated to the radionuclide chelator DOTA, with a mean IC50 of 2.7 nM for binding to FAP. Rofapitide tetraxetan can be radiolabeled for imaging (⁶⁸Ga, ¹¹¹In) or therapy (¹⁷⁷Lu). ¹⁷⁷Lu-FAP-2286 shows antitumor activity in FAP-expressing tumor models. |
|---|
References |
|
| Molecular Formula | C67H99N13O18S3 |
|---|---|
| Molecular Weight | 1470.78 |
| CAS No. | 2581741-18-4 |
| Storage (From the date of receipt) |
3 years-20°C(in the dark) powder |
| Shipping | Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.) |
Read more about